Protia (KOSDAQ:A303360) - Stock Price, News & Analysis

A303360 Stock Overview

Designs, develops, and sells diagnostic kits in South Korea. More details

A303360 fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Has not reported any financial data

Does not have a meaningful market cap (₩33B)

Protia Inc. Competitors

MEKICS

KOSDAQ:A058110

₩35.0b

CU Medical Systems

KOSDAQ:A115480

₩30.4b

Gencurix

KOSDAQ:A229000

₩28.6b

Neofect

KOSDAQ:A290660

₩42.1b

Price History & Performance

Summary of all time highs, changes and price drops for Protia
Historical stock prices
Current Share Price	₩2,580.00
52 Week High	₩3,590.00
52 Week Low	₩2,565.00
Beta	0
11 Month Change	-13.57%
3 Month Change	-16.23%
1 Year Change	-9.63%
33 Year Change	-60.61%
5 Year Change	-66.05%
Change since IPO	-71.33%

Recent updates

Shareholder Returns

	A303360	KR Medical Equipment	KR Market
7D	-8.8%	6.1%	-2.8%
1Y	-9.6%	14.9%	-3.4%

Return vs Industry: A303360 underperformed the KR Medical Equipment industry which returned 14.9% over the past year.

Return vs Market: A303360 underperformed the KR Market which returned -3.4% over the past year.

Price Volatility

Is A303360's price volatile compared to industry and market?
A303360 volatility
A303360 Average Weekly Movement	5.4%
Medical Equipment Industry Average Movement	7.0%
Market Average Movement	5.7%
10% most volatile stocks in KR Market	11.5%
10% least volatile stocks in KR Market	2.7%

Stable Share Price: A303360 has not had significant price volatility in the past 3 months compared to the KR market.

Volatility Over Time: A303360's weekly volatility (5%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
2000	n/a	Kook Jin Lim	www.protia.co.kr

Protia Inc. designs, develops, and sells diagnostic kits in South Korea. The company offers PROTIA Allergy-Q, an assay kit for quantitative determination of specific IgE antibodies against individual allergens in human serum using immunoblotting technique; ImmuneCheck IgG, a whole blood test kit for total IgG concentration measurement; and TriCheck-C, an in vitro diagnostic kit for the qualitative test of human chorionic gonadotropin in human urine samples for the pregnancy diagnosis. It also provides protia food iga, a chronic food intolerance test to identify the foods that do not fit, and stay healthy; anitia canine ige, a serum to identify the cause of the allergy; anicheck bovine igg, a colostrum for feeding calves.

Protia Inc. Fundamentals Summary

How do Protia's earnings and revenue compare to its market cap?
A303360 fundamental statistics
Market cap	₩33.22b
Earnings (TTM)	₩0
Revenue (TTM)	n/a

n/a

P/E Ratio

n/a

P/S Ratio

Is A303360 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A303360 income statement (TTM)
Revenue	₩0
Cost of Revenue	₩0
Gross Profit	₩0
Other Expenses	₩0
Earnings	₩0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did A303360 perform over the long term?

See historical performance and comparison

Protia KOSDAQ:A303360 Stock Report